117 related articles for article (PubMed ID: 17489844)
1. Genetic counselling and consent for tumour testing in HNPCC.
Gaff CL; Rogers MT; Frayling IM
Clin Genet; 2007 May; 71(5):400-5. PubMed ID: 17489844
[TBL] [Abstract][Full Text] [Related]
2. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
3. Variability and inequity in testing of somatic tissue for hereditary cancer: a survey of UK clinical practice.
Gaff CL; Rogers MT; Frayling IM
Clin Genet; 2006 Oct; 70(4):312-9. PubMed ID: 16965325
[TBL] [Abstract][Full Text] [Related]
4. Genetic counselling protocols for hereditary non-polyposis colorectal cancer: a survey of UK regional genetics centres.
Brain K; Soldan J; Sampson J; Gray J
Clin Genet; 2003 Mar; 63(3):198-204. PubMed ID: 12694229
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing for hereditary nonpolyposis colorectal cancer.
Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
7. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.
Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392
[TBL] [Abstract][Full Text] [Related]
8. An exploratory comparison of genetic counselling protocols for HNPCC predictive testing.
Brain K; Sivell S; Bennert K; Howell L; France L; Jordan S; Rogers MT; Gray J; Sampson J
Clin Genet; 2005 Sep; 68(3):255-61. PubMed ID: 16098015
[TBL] [Abstract][Full Text] [Related]
9. [A new oncogenetic service of counseling and diagnosing for hereditary non-polyposis colorectal cancer (HNPCC)].
Goldberg Y; Porat R; Sagi M; Eilat A; Kedar I; Shochat C; Mendelson S; Hamburger T; Nissan A; Hubert A; Shalev S; Bercovich D; Pikarski E; Lerer I; Abeliovich D; Pretetz T
Harefuah; 2007 Jul; 146(7):510-4, 576, 575. PubMed ID: 17803162
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary colorectal carcinoma: predictive diagnosis and genetic counseling].
Mangold E; Friedl W; Propping P
Praxis (Bern 1994); 2001 Mar; 90(12):490-6. PubMed ID: 11324308
[TBL] [Abstract][Full Text] [Related]
11. [Gene testing of hereditary cancer on comprehensive gene medical examination support system].
Shirahama S; Ito T; Hosoya M; Kosaki T; Ijuin J; Kakimoto A; Ishihara Y; Tamura K; Sugai S; Arai M; Miki Y; Muto T; Utsunomiya J
Gan To Kagaku Ryoho; 2005 Jul; 32(7):957-61. PubMed ID: 16044955
[TBL] [Abstract][Full Text] [Related]
12. Adherence to guidelines for the referral of patients with colorectal cancer and abnormal tumour tissue testing for assessment of Lynch syndrome.
Han J; Spigelman AD
ANZ J Surg; 2019 Oct; 89(10):1281-1285. PubMed ID: 30856687
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics improves the management of hereditary non-polyposis colorectal cancer.
Ramesar RS; Madden MV; Felix R; Harocopos CJ; Westbrook CA; Jones G; Cruse JP; Goldberg PA
S Afr Med J; 2000 Jul; 90(7):709-14. PubMed ID: 10985134
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
[TBL] [Abstract][Full Text] [Related]
15. On the limits of genetic responsibility: communication and consent for tumour testing for Lynch syndrome.
Shipman HE; Arribas-Allyon M; Murray A; Gaff CL
Commun Med; 2013; 10(3):225-35. PubMed ID: 25233560
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J
Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the detection of hereditary non-polyposis colorectal cancer: an update.
De Bruin JH; Ligtenberg MJ; Nagengast FM; Adang EM; Van Krieken JH; Hoogerbrugge N
Scand J Gastroenterol Suppl; 2006; (243):146-52. PubMed ID: 16782634
[TBL] [Abstract][Full Text] [Related]
18. Hereditary non-polyposis colorectal cancer: an updated review.
Anwar S; Hall C; White J; Deakin M; Farrell W; Elder JB
Eur J Surg Oncol; 2000 Nov; 26(7):635-45. PubMed ID: 11078609
[TBL] [Abstract][Full Text] [Related]
19. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology.
Batra S; Valdimarsdottir H; McGovern M; Itzkowitz S; Brown K
Am J Gastroenterol; 2002 Mar; 97(3):729-33. PubMed ID: 11922570
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.
Aktan-Collan K; Mecklin JP; de la Chapelle A; Peltomäki P; Uutela A; Kääriäinen H
J Med Genet; 2000 Feb; 37(2):108-13. PubMed ID: 10662810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
